冠動脈疾患のための薬剤塗りたバルーン: 理論から実践へ

Mohamad B Moumneh¹, Yasser Jamil¹, Michael G Nanna²

¹Inova Center of Outcomes Research, 3300 Gallows Road, Falls Church, VA 22042, USA.

Current treatment options in cardiovascular medicine

|September 2, 2025

まとめ

薬で覆われた気球 (DCB) は,冠動脈疾患 (CAD) の伝統的な治療法に価値ある代替手段を提供します. 腸内静止症や小血管疾患など様々な疾患に有効です

科学分野:

心臓病科
介入心臓科
医療機器

背景:

経皮冠動脈干渉 (PCI) と薬剤排出ステントは冠動脈疾患 (CAD) の標準でした.
ステントの狭窄や出血のリスクの増加などの制限は,薬で覆われた気球 (DCB) の開発を促した.

研究の目的:

現在の冠動脈疾患 (CAD) の管理における薬物コーティングバルーン (DCB) の役割を検討する.
DCBの使用の臨床的徴候と技術的考慮に焦点を当てること.
国際DCBコンセンサスグループからの洞察を組み込む.

主な方法:

CADにおけるDCBの使用に関する現在の文献とコンセンサスガイドラインのレビュー.
DCBの使用の臨床的徴候と技術的側面の分析
多様な患者集団におけるDCBの有効性を支持する証拠の統合.

主要な成果:

ドラッグコーテッドバルーン (DCB) は,インステント・レステノシス,小血管疾患,分岐,高出血リスクの患者の治療のために確立されています.
DCBは,急性冠動脈症候群および糖尿病患者にも用いる.
最適な結果は機能的評価,病変の準備,そして慎重に患者の選択を必要とする.

結論:

薬で覆われた気球 (DCB) は,冠動脈疾患 (CAD) の管理における重要な進歩を表しています.
継続的なDCB技術の革新とさらなる臨床試験により,その応用が拡大される見込みです.
DCBの有効な使用は,最適な薬物投与と合併症の減少のために細心の注意を払った手順計画と患者の選択を必要とします.

キーワード:

冠動脈疾患薬で覆われた気球経皮冠動脈介入

さらに関連する動画

06:39

Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease

Published on: February 18, 2020

6.9K

14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

8.6K

関連する概念動画

01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...

01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

673

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

673

01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

関連する実験動画

冠動脈 疾患 の ため の 薬剤 塗り た バルーン: 理論 から 実践 へ